Fig. 6: 8-year longitudinal follow-up of serum miRNA levels in DaT-negative and DaT-positive L2NMC groups with respect to their corresponding baselines.
From: Differential serum microRNAs in premotor LRRK2 G2019S carriers from Parkinson’s disease
Longitudinal fold-change values in a DaT-negative L2NMC and b DaT-positive L2NMC. DaT DaT-SPECT imaging, L2NMC LRRK2 non-manifesting carriers.
